European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.

Mission

The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'

European Drugs Summer School 2021

Lisbon,

The two week Summer School prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs. Teaching staff include scientific experts from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), researchers, practitioners and policymakers.

This edition will have a special focus on illicit drugs and vulnerable groups.

European Drugs Winter School 2021

Europe,

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are offering two upcoming events in 2021: the European Drugs Winter School (EDWS) and the European Drugs Summer School (EDSS).

The EDWS will take place as a virtual event from 1–12 March 2021 and will explore the theme of 'Responses to, and preparedness for, health-related threats (COVID-19 lessons learned)'. 

EMCDDA Technical Report on New Psychoactive Substance

Published by
EMCDDA

The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid agonist that has recently emerged on the drug market in Europe, in order to support the risk assessment of the substance which has been requested by the European Commission.

Reitox National Focal Points’ Activities During the COVID-19 Pandemic

Published by
EMCDDA

Reitox is the European information network on drugs and drug addiction created at the same time as the EMCDDA.

Members of the Reitox network are designated national institutions or agencies responsible for data collection and reporting on drugs and drug addiction. These institutions are called 'national focal points' or 'national drug observatories'.

EMCDDA webinar: COVID-19 induced recession and drug-related problems

Online,

The EMCDDA is offering a series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for a panel discussion on emerging challenges.

Registration opens for European Drugs Winter and Summer Schools 2021

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are pleased to open registration today for two upcoming joint events in 2021: the European Drugs Winter School (EDWS) and the European Drugs Summer School (EDSS). EDWS 1–12 March 2021 (online): Following the success of the EDSS in 2020, taught remotely due to the COVID-19 pandemic, the organisers have decided to deliver the first virtual EDWS in 2021. The theme of the event will be Responses

European Drug Report 2020

Published by
EMCDDA
Publication Date

European Drug Report 2020

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets 
What do the latest data tell us about drug production and trafficking trends?

European Drug Report 2020 Launch

Lisbon,

How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production and trafficking trends? Be the first to know when the EU drugs agency (EMCDDA) launches its European Drug Report 2020: Trends and Developments in a live online media event on 22 September.